7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Zhang L et al. | Effects of IL-10 and glucose on expression of OPG and RANKL in human periodontal ligament fibroblasts. | 2016 | Braz. J. Med. Biol. Res. | pmid:27074164 |
Song DH et al. | Relationships of OPG Genetic Polymorphisms with Susceptibility to Cardiovascular Disease: A Meta-Analysis. | 2016 | Med. Sci. Monit. | pmid:27068490 |
Kose O et al. | Influences of Fucoxanthin on Alveolar Bone Resorption in Induced Periodontitis in Rat Molars. | 2016 | Mar Drugs | pmid:27043583 |
Shah AP et al. | Effects of Minocycline on Urine Albumin, Interleukin-6, and Osteoprotegerin in Patients with Diabetic Nephropathy: A Randomized Controlled Pilot Trial. | 2016 | PLoS ONE | pmid:27019421 |
Johnson DC et al. | Genetic factors influencing the risk of multiple myeloma bone disease. | 2016 | Leukemia | pmid:26669972 |
Davaine JM et al. | Bone Like Arterial Calcification in Femoral Atherosclerotic Lesions: Prevalence and Role of Osteoprotegerin and Pericytes. | 2016 | Eur J Vasc Endovasc Surg | pmid:26652270 |
Liu HJ et al. | Substance P Promotes the Proliferation, but Inhibits Differentiation and Mineralization of Osteoblasts from Rats with Spinal Cord Injury via RANKL/OPG System. | 2016 | PLoS ONE | pmid:27764190 |
Menzel J et al. | Association between omentin-1, adiponectin and bone health under consideration of osteoprotegerin as possible mediator. | 2016 | J. Endocrinol. Invest. | pmid:27614458 |
O'Sullivan S et al. | Tyrosine Kinase Inhibitors Regulate OPG through Inhibition of PDGFRβ. | 2016 | PLoS ONE | pmid:27737004 |
Li M et al. | Heparan Sulfate Regulates the Structure and Function of Osteoprotegerin in Osteoclastogenesis. | 2016 | J. Biol. Chem. | pmid:27697839 |
Sun J et al. | Daidzein increases OPG/RANKL ratio and suppresses IL-6 in MG-63 osteoblast cells. | 2016 | Int. Immunopharmacol. | pmid:27576059 |
Yu M et al. | Chemotherapy effectively suppresses interleukin-20, receptor activator of nuclear factor kappa-B ligand, and osteoprotegerin levels in patients with lung adenocarcinoma and bone metastasis. | 2016 Apr-Jun | J Cancer Res Ther | pmid:27461682 |
Middleton K et al. | Microfluidic co-culture platform for investigating osteocyte-osteoclast signalling during fluid shear stress mechanostimulation. | 2017 | J Biomech | pmid:28552413 |
Jung YJ et al. | Tannerella forsythia GroEL induces inflammatory bone resorption and synergizes with interleukin-17. | 2017 | Mol Oral Microbiol | pmid:27484636 |
Lu LY et al. | Pro-inflammatory M1 macrophages promote Osteogenesis by mesenchymal stem cells via the COX-2-prostaglandin E2 pathway. | 2017 | J. Orthop. Res. | pmid:28248001 |
Kuroyanagi G et al. | (-)-Epigallocatechin gallate synergistically potentiates prostaglandin E2-stimulated osteoprotegerin synthesis in osteoblasts. | 2017 | Prostaglandins Other Lipid Mediat. | pmid:28163121 |
Liu XY et al. | Protective effects of total flavonoids of Astragalus against adjuvant-induced arthritis in rats by regulating OPG/RANKL/NF-κB pathway. | 2017 | Int. Immunopharmacol. | pmid:28092862 |
Choi EM et al. | Actein alleviates 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated cellular dysfunction in osteoblastic MC3T3-E1 cells. | 2017 | Environ. Toxicol. | pmid:28836330 |
Chen X et al. | Emodin suppresses cadmium-induced osteoporosis by inhibiting osteoclast formation. | 2017 | Environ. Toxicol. Pharmacol. | pmid:28738286 |
Ozaki Y et al. | Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis. | 2017 | PLoS ONE | pmid:28937990 |
Tschiderer L et al. | Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participants. | 2017 | PLoS ONE | pmid:28837646 |
Åšliwicka E et al. | Serum irisin and myostatin levels after 2 weeks of high-altitude climbing. | 2017 | PLoS ONE | pmid:28732027 |
Bergdolt S et al. | Osteoblast-specific overexpression of complement receptor C5aR1 impairs fracture healing. | 2017 | PLoS ONE | pmid:28614388 |
Spirlandeli AL et al. | Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment. | 2017 | Clinics (Sao Paulo) | pmid:28492723 |
Liu J et al. | MicroRNA-32 promotes calcification in vascular smooth muscle cells: Implications as a novel marker for coronary artery calcification. | 2017 | PLoS ONE | pmid:28319142 |
Songia P et al. | Identification of Patients Affected by Mitral Valve Prolapse with Severe Regurgitation: A Multivariable Regression Model. | 2017 | Oxid Med Cell Longev | pmid:28261377 |
Jia J et al. | Estrogen stimulates osteoprotegerin expression via the suppression of miR-145 expression in MG-63 cells. | 2017 | Mol Med Rep | pmid:28260003 |
Shetelig C et al. | Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function. | 2017 | PLoS ONE | pmid:28253327 |
Irtyuga O et al. | NOTCH1 Mutations in Aortic Stenosis: Association with Osteoprotegerin/RANK/RANKL. | 2017 | Biomed Res Int | pmid:28246602 |
Hanmoto T et al. | Effects of low-intensity pulsed ultrasound on osteoclasts: Analysis with goldfish scales as a model of bone. | 2017 | Biomed. Res. | pmid:28239034 |
Fioramonti M et al. | Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions. | 2017 | Oncotarget | pmid:28223547 |
Xiong L et al. | Osteoblastic Lrp4 promotes osteoclastogenesis by regulating ATP release and adenosine-A2AR signaling. | 2017 | J. Cell Biol. | pmid:28193701 |
Fortner RT et al. | Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort. | 2017 | BMC Med | pmid:28173834 |
Chung ST et al. | Osteoprotegerin mediates tumor-promoting effects of Interleukin-1beta in breast cancer cells. | 2017 | Mol. Cancer | pmid:28143606 |
Yin LL et al. | Relationship between the gene polymorphism of osteoprotegerin and bone mineral density in hemodialysis patients. | 2017 | Eur Rev Med Pharmacol Sci | pmid:28121359 |
Bondar C et al. | Osteocyte Alterations Induce Osteoclastogenesis in an In Vitro Model of Gaucher Disease. | 2017 | Int J Mol Sci | pmid:28098793 |
Shu R et al. | Sclerostin Promotes Bone Remodeling in the Process of Tooth Movement. | 2017 | PLoS ONE | pmid:28081119 |
Ji J et al. | Pathway of 3-MCPD-induced apoptosis in human embryonic kidney cells. | 2017 | J Toxicol Sci | pmid:28070108 |
Sponder M et al. | Endurance training significantly increases serum endocan but not osteoprotegerin levels: a prospective observational study. | 2017 | BMC Cardiovasc Disord | pmid:28056805 |
Hygum K et al. | MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis. | 2017 | Eur. J. Endocrinol. | pmid:28049653 |
Dawson S and Lawrie A | From bones to blood pressure, developing novel biologic approaches targeting the osteoprotegein pathway for pulmonary vascular disease. | 2017 | Pharmacol. Ther. | pmid:27373854 |